President & CEO of Accuray Inc (ARAY, Financial) Joshua Levine bought 25,000 shares of ARAY on 11/05/2018 at an average price of $4.75 a share. The total cost of this purchase was $118,750.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise treatment solutions. Its products includes the CyberKnife Systems and the TomoTherapy Systems. Accuray Inc has a market cap of $422.100 million; its shares were traded at around $4.88 with and P/S ratio of 1.02.
CEO Recent Trades:
- President & CEO Joshua Levine bought 25,000 shares of ARAY stock on 11/05/2018 at the average price of $4.75. The price of the stock has increased by 2.74% since.
- President & CEO Joshua Levine sold 43,257 shares of ARAY stock on 11/01/2018 at the average price of $4.66. The price of the stock has increased by 4.72% since.
Directors and Officers Recent Trades:
- Director Joseph E Whitters bought 25,000 shares of ARAY stock on 11/05/2018 at the average price of $4.68. The price of the stock has increased by 4.27% since.
- SVP and General Counsel Jesse Chew sold 1,846 shares of ARAY stock on 11/01/2018 at the average price of $4.24. The price of the stock has increased by 15.09% since.
For the complete insider trading history of ARAY, click here
.
